Heilongjiang ZBD Pharmaceutical Co. Ltd. A | Cash Flow
Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
424,816.20
464,053.40
579,767.00
496,659.20
523,199.90
463,402
Depreciation, Depletion & Amortization
76,984.70
102,416.60
123,790.40
161,957.40
136,408.70
138,941.70
Other Funds
40,463.00
101,300.50
1,475,781.10
43,175.50
47,956.60
192,066.80
Funds from Operations
578,192.70
615,046.30
724,031.90
669,026.80
784,300.00
751,174.90
Changes in Working Capital
399,509.10
224,722.60
1,047,926.90
643,668.80
77,564.40
379,771.60
Net Operating Cash Flow
178,683.60
390,323.60
323,895.00
25,358.00
861,864.50
371,403.20
Capital Expenditures
168,725.70
79,853.10
69,961.00
318,744.30
492,423.60
Sale of Fixed Assets & Businesses
82.40
6,258.00
420.40
29,189.20
2,518.50
Purchase/Sale of Investments
-
-
-
22,840.80
396,000.00
Net Investing Cash Flow
175,345.40
73,595.20
76,094.70
314,092.80
37,160.30
Cash Dividends Paid - Total
-
-
200,000.00
212,290.00
153,698.00
Issuance/Reduction of Debt, Net
550,000.00
315,000.00
280,293.50
397,700.00
30,000.00
Net Financing Cash Flow
509,537.00
416,300.50
1,556,074.60
142,234.50
231,654.60
Net Change in Cash
512,875.20
99,572.00
1,156,084.80
146,500.30
593,049.60
Free Cash Flow
9,957.90
310,470.50
393,856.10
293,386.30
369,440.80
Deferred Taxes & Investment Tax Credit
13,329.20
10,625.20
67,069.70
28,175.10
27,000.90
43,235.60
Net Assets from Acquisitions
-
-
6,554.00
1,697.00
4,755.20
Other Sources
29,980.00
-
-
-
61,500.00
Other Uses
36,682.00
-
-
-
-
About Heilongjiang ZBD Pharmaceutical Co.
View Profile
